---
$id: https://graph.org.ai/products/commodity/51263114
$type: Product
source: UNSPSC
code: "51263114"
title: "Bunitrolol"
class: "51263100"
classTitle: "Adrenergic blocking agent propanolamines"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Bunitrolol

**UNSPSC Code**: 51263114
**Class**: [Adrenergic blocking agent propanolamines](Adrenergic blocking agent propanolamines.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a beta-adrenergic blocking agent with the molecular formula C14H20N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F2613LO055, chemically known as 2-propanol, 3-(tert-butylamino)-1-(m-cyanophenoxy)- but generally known as bunitrolol, which bears US NIH Compound Identifier 2473. Bunitrolol most often comes in base and hydrochloride forms. European Medicines Agency schedules Bunitrolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05978MIG. The term BUNITROLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13). BUNITROLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bunitrolol under HS 29269095 and SITC 51484. As of Q4 2014, BUNITROLOL remains the US FDA Preferred Term for this commodity. Bunitrolol bears US NLM identifiers UMLS ID C0006387 and NCI Concept Code C72614. SMILES: OC(CNC(C)(C)C)COC1C(CCCC1)C#N.

